Eplerenone reduces mortality 30 days after randomization following acute myocardial infarction in patients with left ventricular systolic dysfunction and heart failure

Journal of the American College of Cardiology

Volumn 46, Issue 3, 2005, Pages 425-431

  Pitt, Bertram ^a,k   White, Harvey ^b   Nicolau, Jose ^c   Martinez, Felipe ^d   Gheorghiade, Mihai ^e   Aschermann, Michael ^f   Van Veldhuisen, Dirk J ^g   Zannad, Faiez ^h   Krum, Henry ⁱ   Mukherjee, Robin ^j   Vincent, John ^j  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b AUCKLAND CITY HOSPITAL   (New Zealand)

^c UNIVERSITY OF SÃO PAULO   (Brazil)

^d Fundacion Rusculleda   (Argentina)

^e NORTHWESTERN UNIVERSITY   (United States)

^f UNIVERSITY HOSPITAL OSTRAVA   (Czech Republic)

^g UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^h Ctr Hospitalier Univ de Nancy   (France)

ⁱ MONASH UNIVERSITY   (Australia)

^j PFIZER INC   (United States)

^k UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALDOSTERONE ANTAGONIST; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; EPLERENONE; FIBRINOLYTIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PLACEBO; RADIOISOTOPE;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; BLOOD CLOT LYSIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; FATALITY; FEMALE; FOLLOW UP; HEART FAILURE; HEART LEFT VENTRICLE CONTRACTION; HEART LEFT VENTRICLE EJECTION FRACTION; HOSPITALIZATION; HUMAN; HYPERKALEMIA; HYPOKALEMIA; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTICENTER STUDY; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SUDDEN DEATH;

AGED; CORONARY ANGIOGRAPHY; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE, CONGESTIVE; HEART FUNCTION TESTS; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PROBABILITY; PROPORTIONAL HAZARDS MODELS; REFERENCE VALUES; SEVERITY OF ILLNESS INDEX; SPIRONOLACTONE; TREATMENT OUTCOME; VENTRICULAR DYSFUNCTION, LEFT;

EID: 22844437062     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2005.04.038     Document Type: Article

References (22)

1. P.G. Steg, O.H. Dabbous, L.J. Feldman Determinants and prognostic impact of heart failure complicating acute coronary syndromes observations from the Global Registry of Acute Coronary Events (GRACE) Circulation 109 2004 494 499
2. A.H. Wu, L. Parsons, N.R. Every, E.R. Bates Hospital outcomes in patients presenting with congestive heart failure complicating acute myocardial infarction a report from the Second National Registry of Myocardial Infarction (NRMI-2) J Am Coll Cardiol 40 2002 1389 1394
3. E.J. Velazquez, G.S. Francis, P.W. Armstrong VALIANT registry An international perspective on heart failure and left ventricular systolic dysfunction complicating myocardial infarction the VALIANT registry Eur Heart J 25 2004 1911 1919
4. F.A. Spencer, T.E. Meyer, J.M. Gore, R.J. Goldberg Heterogeneity in the management and outcomes of patients with acute myocardial infarction complicated by heart failure the National Registry of Myocardial Infarction Circulation 105 2002 2605 2610
5. M.A. Pfeffer, J.J. McMurray, E.J. Velazquez Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both N Engl J Med 349 2003 1893 1906
6. D.A. Hasdai, E.J. Topol, R. Kilaru Frequency, patient characteristics, and outcomes of mild-to-moderate heart failure complicating ST-segment elevation acute myocardial infarction lessons from 4 international fibrinolytic therapy trials Am Heart J 145 2003 73 79
7. B. Pitt, W. Remme, F. Zannad Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction N Engl J Med 348 2003 1309 1321
8. G.C. Fonarow, A. Gawlinski, S. Moughrabi, J.H. Tillisch Improved treatment of coronary heart disease by implementation of a Cardiac Hospitalization Atherosclerosis Management Program (CHAMP) Am J Cardiol 87 2001 819 822
9. W.J. Rogers, R.C. Bourge, S.E. Papapietro Variables predictive of good functional outcome following thrombolytic therapy in the Thrombolysis in Myocardial Infarction phase II (TIMI II) pilot study Am J Cardiol 63 1989 503 512
10. M. Hayashi, T. Tsutamoto, A. Wada Immediate administration of mineralocorticoid receptor antagonist spironolactone prevents post-infarct left ventricular remodeling associated with suppression of a marker of myocardial collagen synthesis in patients with first anterior acute myocardial infarction Circulation 107 2003 2559 2565
11. J.A. Delyani, E.L. Robinson, A.E. Rudolph Effect of a selective aldosterone receptor antagonist in myocardial infarction Am J Physiol Heart Circ Physiol 281 2001 H647 H654
12. E. Perrier, B.G. Kerfant, N. Lalevee Mineralocorticoid receptor antagonism prevents the electrical remodeling that precedes cellular hypertrophy after myocardial infarction Circulation 110 2004 776 783
13. M. Hayashi, T. Tsutamoto, A. Wada Relationship between transcardiac extraction of aldosterone and left ventricular remodeling in patients with first acute myocardial infarction extracting aldosterone through the heart promotes ventricular remodeling after acute myocardial infarction J Am Coll Cardiol 38 2001 1375 1382
14. F. Zannad, J.-M. Ketelslegers, E.L. Schiffrin The effect of eplerenone on markers of cardiac fibrosis insights from EPHESUS (abstr) J Am Coll Cardiol 43 Suppl A 2004 200A
15. M.G. Sutton, N. Sharpe Left ventricular remodeling after myocardial infarction pathophysiology and therapy Circulation 101 2000 2981 2988
16. J.E. Udelson, R.D. Patten, M.A. Konstam New concepts in post-infarction ventricular remodeling Rev Cardiovasc Med 4 Suppl 3 2003 S3 S12
17. G.F. Tomaselli, D.P. Zipes What causes sudden death in heart failure? Circ Res 95 2004 754 763
18. C.S. Barr, C.C. Lang, J. Hanson, M. Arnott, N. Kennedy, A.D. Struthers Effects of adding spironolactone to an angiotensin-converting enzyme inhibitor in chronic congestive heart failure secondary to coronary artery disease Am J Cardiol 76 1995 1259 1265
19. D. Fraccarollo, P. Galuppo, S. Hildemann, M. Christ, G. Ertl, J. Bauersachs Additive improvement of left ventricular remodeling and neurohormonal activation by aldosterone receptor blockade with eplerenone and ACE inhibition in rats with myocardial infarction J Am Coll Cardiol 42 2003 1666 1673
20. R.J. MacFadyen, C.S. Barr, A.D. Struthers Aldosterone blockade reduces vascular collagen turnover, improves heart rate variability and reduces early morning rise in heart rate in heart failure patients Cardiovasc Res 35 1997 30 34
21. W. Wang Chronic administration of aldosterone depresses baroreceptor reflex function in the dog Hypertension 24 1994 571 575
22. J. Francis, R.M. Weiss, S.G. Wei Central mineralocorticoid receptor blockade improves volume regulation and reduces sympathetic drive in heart failure Am J Physiol Heart Circ Physiol 281 2001 H2241 H2251